Antimicrobials 2019
 
 
Plenary Speakers


Dr Romney Humphries

Accelerate Diagnostics Inc, United States of America

Professor Jesús Rodriguez Baño
Hospital Universitario Virgen Macarena, University of Seville, Biomedicine Institute of Seville, Spain

Professor Karin Thursky
The University of Melbourne, Victoria



Dr Romney Humphries

Dr Romney Humphries, Chief Scientific Officer at Accelerate Diagnostics, is highly regarded within the Microbiology and Infectious Diseases communities for her expertise, research, and contributions to the Clinical and Laboratory Standards Institute. She is particularly well known for her interest and publications in the area of antimicrobial susceptibility testing, new diagnostic technologies, and her work to address common issues faced by clinical microbiology laboratories. She is published in more than 100 scientific peer-reviewed papers in journals such as Clinical Infectious Diseases and Journal of Clinical Microbiology. Additionally, she has been invited to speak at over one hundred academic workshops and scientific conferences around the world. Dr Humphries also serves on several committees and working groups for organisations including the American Society for Microbiology, the Clinical Laboratory and Standards Institute, the U.S. Food and Drug Administration, and the World Health Organisation.

Professor Jesús Rodriguez Baño

Professor Jesús Rodriguez Baño is a specialist in Internal Medicine; Expert degree in Epidemiology and Clinical Research; Professor of Medicine, Universidad de Sevilla. Head of Infectious Diseases Division at Hospital Universitario Virgen Macarena; Scientific coordinator of the Spanish Network for Research in Infectious Diseases (REIPI); and President, European Society of Clinical Microbiology and Infectious Diseases (ESCMID). He has authored over 280 peer-reviewed scientific papers.

On behalf of the Australian Society for Antimicrobials, the ASA Executive wishes to congratulate Professor Rodriguez Baño for recently receiving the Research Award of the Spanish Plan Against Antimicrobial Resistance from the Spanish Ministry of Health. 

Professor Rodgriguez Baño will be presenting the plenary "New Antimicrobials: Can we Avoid our Past Mistakes?". In addition, he will be participating in the "Difficult to Treat Populations" symposium where he will be presenting "Treatment of Older Patients with Multi Resistant Gram Negative Bacteria".


Professor Karin Thursky

Professor Karin Thursky is the Director of the National Centre for Antimicrobial Stewardship, a health services Centre for Research Excellence under the NHMRC, which is taking a one health approach to the challenges of optimising antimicrobial usage across both human and animal health. NCAS has a key role in the implementation of the National Antimicrobial Resistance strategy. She is an infectious diseases physician and clinician researcher working at Peter MacCallum Cancer Centre and Royal Melbourne Hospital at the Peter Doherty Institute. Her research spans both paediatric and adult medicine, immunocompromised patients, primary and secondary healthcare, as well as veterinary antimicrobial stewardship. She is the lead of the implementation stream for the Centre of Research Excellence - National Centre for Infections in Cancer Centre for Research Excellence based at Peter Mac, which includes implementation of clinical pathways for sepsis, neutropenic fever and antibiotic allergy management. She is a national leader and recognised international expert in the design and implementation of antimicrobial stewardship programs, with extensive expertise in the role of information technology. Karin has active roles with the Australian Commission of Safety and Quality in Healthcare as an expert advisor for the Antimicrobial Usage and Resistance in Australia program, and the antimicrobial stewardship advisory group.


Keynote Speakers



Prof Jan Kluytmans
University Medical Center Utrecht, Utrecht University, Netherlands

Mr Mark Gilchrist
Imperial College Healthcare NHS Trust, United Kingdom


Prof Jan Kluytmans

Jan Kluytmans did his medical training as well as specialization in Clinical Microbiology at Erasmus Medical University, Rotterdam, The Netherlands. The title of his PhD thesis in 1996, was: Nasal carriage of Staphylococcus aureus: the key to preventing staphylococcal disease. His scientific career focuses on the epidemiology and control of nosocomial infections, with a special interest in Staphylococcus aureus, surgical site infections and control of antimicrobial resistance. He discovered the concept of perioperative eradication of nasal carriage as an infection control measure. More recently his investigations have included the impact of agricultural antibiotic use on the development of resistance in animals, food items and humans. Also he is developing a tool to measure the quality of infection control and of the control of antimicrobial resistance in healthcare facilities. He has been involved in many national and international guidelines on infection control, especially those dealing with the control of MRSA and the prevention of surgical site infections. Until 2013 he was the chair of the Dutch Working Party on Infection Control. Since November 2013 he is the chair of the Dutch Society of Medical Microbiology. At present he is working in the Amphia Hospital in Breda/Oosterhout, St. Elisabeth Hospital and TweeSteden Hospital in Tilburg. From 2006 – 2014 he was a Professor of Medical Microbiology and Infection Control at the VU university medical center in Amsterdam. In 2014 he moved to the University Medical Center Utrecht, Julius Center, where he is Professor for the epidemiology of Healthcare-related infections. He leads several work packages within the No Drugs for Bad Bugs (ND4BB) program focused at the epidemiology of S. aureus within Europe. Since 2017 he is the leader of the i41-health crossborder project between The Netherlands and Belgium. He has more than 300 papers in peer-reviewed journals and given more than 500 presentations and lectures.


Mr Mark Gilchrist

Mark is Consultant Pharmacist Infectious Diseases & Stewardship at Imperial College Healthcare NHS Trust. He is a council member of the British Society of Antimicrobial Chemotherapy and co-chairs its UK OPAT initiative. He is a senior honorary lecturer at Imperial College London, together with being a spokesman on antimicrobials and fellow of the Royal Pharmaceutical Society. Mark has particular interests in antimicrobial stewardship around improving systems and processes that affect local, national and international AMR. His clinical interests include OPAT, tuberculosis and critical care.

Postgraduate education includes an MSc and non-medical independent prescribing status and he was recently awarded the NHS Leadership Academy Nye Bevan Award in executive healthcare leadership. He is past chair of the UK Clinical Pharmacy Association - Pharmacy Infection Network (UKCPA PIN) and was awarded the RPS Faculty Fellowship (Infection) in 2013.

He has delivered many lectures and workshops on AMS both at national and international level and has published around his areas of interest. He was a member of the working group that reviewed and developed the Public Health England "Start Smart then Focus" stewardship toolkit and co-authored the UKCPA/RPS Faculty infection curriculum. Mark was a tutor on the global massive open online course on AMS and is an editor for Pharmacotherapy and Journal of Antimicrobial stewardship.